literature.cafe

512 readers
12 users here now
(and anyone else, really)

This is a general special interest lemmy instance focusing on lovers of all things pertaining to reading and writing and all of the people that enjoy it as well as fandoms and niches that exist within reading circles. We federate with other instances, with our local communities being focused primarily on the above.

If you want to federate a new community, go to lemmyverse.net and copy a link to a community and paste it into the search bar. Be patient!

Also, consider installing instance assistant to better navigate lemmy and find communities better! Find links to download them here: firefox, chrome, edge


Instance Rules
  1. Keep it cozy. (No -isms, bigotry, gatekeeping, or general disrespect. Just be nice!)
  2. Please, no visual porn. (Smut and discussion of smut is OK as long as it is tagged as NSFW.)
  3. No spam.
  4. Be mindful of other instance rules.
  5. Keep self-promo to a minimum.
  6. Tag AI generated content as such.
  7. Please avoid piracy.

Server Info

Registration is open with human approval, just to make sure there's no bots afoot. Approval should take less than a day (and are sometimes near instant)

Please check your spam folder for an email from noreply@literature.cafe if you are having difficulty finding email confirmation.

Community creation is enabled. When creating new communities please be mindful of the instance focus.

If you have any issues or concerns, please message an admin

Fediseer Guarantees


For those visiting from other instances, we have a community directory to make finding communities easier: !411@literature.cafe


We also have alternative lemmy UIs to use for those who want them.

A familiar UI - old.literature.cafe

Photon - ph.literature.cafe

Tesseract (photon fork with more multimedia focused features) - t.literature.cafe


Donations are greatly appreciated and go entirely to server costs but are not required.

List of Patrons Daily Uptime Ratio Weekly Uptime Ratio Average Response Time

founded 1 year ago
ADMINS
1
 
 

U.S. health insurers and benefit plans alleged the consulting giant's work for drug makers prompted them to pay for opioids instead of non-addictive and cheaper drugs

Consulting firm McKinsey & Company has agreed to pay $78 million to settle a lawsuit brought by health insurers and benefit plans over its involvement in the nation's opioid addiction epidemic.

The proposed settlement was filed in a federal California court on Friday and resolved claims by the plaintiffs that McKinsey strategized and acted with opioid makers, including Purdue, to create and execute marketing and sales strategies to "maximize opioid revenue."

The original lawsuit was filed by third-party payers such as private benefit plans, multi-employer pension plans and commercial insurers. They alleged these strategies harmed them by prompting them to pay for prescription opioids instead of safer, non-addictive and cheaper drugs, as well as the "addiction-related treatment that followed."

McKinsey did not admit to any wrongdoing in the settlement. In a statement shared with The Messenger, the firm said "we continue to believe that our past work was lawful."

2
 
 

U.S. health insurers and benefit plans alleged the consulting giant's work for drug makers prompted them to pay for opioids instead of non-addictive and cheaper drugs

Consulting firm McKinsey & Company has agreed to pay $78 million to settle a lawsuit brought by health insurers and benefit plans over its involvement in the nation's opioid addiction epidemic.

The proposed settlement was filed in a federal California court on Friday and resolved claims by the plaintiffs that McKinsey strategized and acted with opioid makers, including Purdue, to create and execute marketing and sales strategies to "maximize opioid revenue."

The original lawsuit was filed by third-party payers such as private benefit plans, multi-employer pension plans and commercial insurers. They alleged these strategies harmed them by prompting them to pay for prescription opioids instead of safer, non-addictive and cheaper drugs, as well as the "addiction-related treatment that followed."

McKinsey did not admit to any wrongdoing in the settlement. In a statement shared with The Messenger, the firm said "we continue to believe that our past work was lawful."

view more: next ›